Literature DB >> 32327294

The Role of Heat Shock Protein-90 in the Pathogenesis of Birt-Hogg-Dubé and Tuberous Sclerosis Complex Syndromes.

Mark R Woodford1, Sarah J Backe1, Rebecca A Sager2, Dimitra Bourboulia1, Gennady Bratslavsky1, Mehdi Mollapour3.   

Abstract

Birt-Hogg-Dubé (BHD) and tuberous sclerosis (TS) syndromes share many clinical features. These two diseases display distinct histologic subtypes of renal tumors: chromophobe renal cell carcinoma and renal angiomyolipoma, respectively. Early work suggested a role for mTOR dysregulation in the pathogenesis of these two diseases, however their detailed molecular link remains elusive. Interestingly, a growing number of case reports describe renal angiomyolipoma in BHD patients, suggesting a common molecular origin. The BHD-associated proteins FNIP1/2 and the TS protein Tsc1 were recently identified as regulators of the molecular chaperone Hsp90. Dysregulation of Hsp90 activity has previously been reported to support tumorigenesis, providing a potential explanation for the overlapping phenotypic manifestations in these two hereditary syndromes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Birt-Hogg-Dubé (BHD); Chaperones; FLCN; Heat Shock Protein-90; Renal Angiomyolipoma; Tsc1 (Hamartin); Tsc2 (Tuberin); Tuberous Sclerosis Complex (TSC)

Mesh:

Substances:

Year:  2020        PMID: 32327294      PMCID: PMC7572595          DOI: 10.1016/j.urolonc.2020.03.016

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   2.954


  52 in total

1.  Identification and characterization of a novel folliculin-interacting protein FNIP2.

Authors:  Hisashi Hasumi; Masaya Baba; Seung-Beom Hong; Yukiko Hasumi; Ying Huang; Masahiro Yao; Vladimir A Valera; W Marston Linehan; Laura S Schmidt
Journal:  Gene       Date:  2008-03-04       Impact factor: 3.688

Review 2.  The Metabolic Basis of Kidney Cancer.

Authors:  W Marston Linehan; Laura S Schmidt; Daniel R Crooks; Darmood Wei; Ramaprasad Srinivasan; Martin Lang; Christopher J Ricketts
Journal:  Cancer Discov       Date:  2019-05-14       Impact factor: 39.397

3.  Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  John J Bissler; J Christopher Kingswood; Elżbieta Radzikowska; Bernard A Zonnenberg; Michael Frost; Elena Belousova; Matthias Sauter; Norio Nonomura; Susanne Brakemeier; Petrus J de Vries; Vicky H Whittemore; David Chen; Tarek Sahmoud; Gaurav Shah; Jeremie Lincy; David Lebwohl; Klemens Budde
Journal:  Lancet       Date:  2013-03-09       Impact factor: 79.321

4.  Birt-Hogg-Dubé syndrome with a renal angiomyolipoma: further evidence of a relationship between Birt-Hogg-Dubé syndrome and tuberous sclerosis complex.

Authors:  Marguerite Byrne; Raj Mallipeddi; Gabriella Pichert; Sean Whittaker
Journal:  Australas J Dermatol       Date:  2011-03-10       Impact factor: 2.875

Review 5.  Hsp90 molecular chaperone inhibitors: are we there yet?

Authors:  Len Neckers; Paul Workman
Journal:  Clin Cancer Res       Date:  2012-01-01       Impact factor: 12.531

6.  Cryo-EM Structure of the Human FLCN-FNIP2-Rag-Ragulator Complex.

Authors:  Kuang Shen; Kacper B Rogala; Hui-Ting Chou; Rick K Huang; Zhiheng Yu; David M Sabatini
Journal:  Cell       Date:  2019-11-06       Impact factor: 66.850

7.  Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.

Authors:  David J Kwiatkowski; Michael R Palmer; Sergiusz Jozwiak; John Bissler; David Franz; Scott Segal; David Chen; Julian R Sampson
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

8.  The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding.

Authors:  Mark R Woodford; Diana M Dunn; Adam R Blanden; Dante Capriotti; David Loiselle; Chrisostomos Prodromou; Barry Panaretou; Philip F Hughes; Aaron Smith; Wendi Ackerman; Timothy A Haystead; Stewart N Loh; Dimitra Bourboulia; Laura S Schmidt; W Marston Linehan; Gennady Bratslavsky; Mehdi Mollapour
Journal:  Nat Commun       Date:  2016-06-29       Impact factor: 14.919

9.  Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases.

Authors:  Constance S Petit; Agnes Roczniak-Ferguson; Shawn M Ferguson
Journal:  J Cell Biol       Date:  2013-09-30       Impact factor: 10.539

10.  Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis.

Authors:  Rebecca A Sager; Mark R Woodford; Oleg Shapiro; Mehdi Mollapour; Gennady Bratslavsky
Journal:  Oncotarget       Date:  2018-04-24
View more
  2 in total

1.  Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.

Authors:  Evelyn M Mrozek; Vineeta Bajaj; Yanan Guo; Izabela A Malinowska; Jianming Zhang; David J Kwiatkowski
Journal:  PLoS One       Date:  2021-04-23       Impact factor: 3.752

Review 2.  Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer.

Authors:  Sarah J Backe; Rebecca A Sager; Katherine A Meluni; Mark R Woodford; Dimitra Bourboulia; Mehdi Mollapour
Journal:  Biomolecules       Date:  2022-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.